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 Summary
 Background:  Unilateral persistent left superior vena cava (PLSVC) is an infrequent finding with incidence of 
18-20% among the individuals with PLSVC. The persistence of the left-sided superior vena cava is 
an effect of disturbances in development of the connection between the precardinal veins (anterior 
cardinal veins) and formation of the sinus venosus in early stages of embryogenesis.
 Case report:  The paper presents a case of a 62-year-old patient with a mass lesion of the left hilum, which 
caused left-sided superior vena caval syndrome in the presence of unilateral PLSVC.
 Conclusions:  Developmental mechanisms of superior vena caval syndrome are discussed. The evolution of changes 
related to infiltration and occlusion of PLSVC is shown on the basis of three selected MSCT examinations.
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Background
Persistent left superior vena cava (PLSVC) is one of the 
most common forms of anomalous systemic venous return. 
It occurs in 0.3-0.5% of the general population, usually as 
a concomitant vein to the right-sided superior vena cava 
(RSVC) [1, 2, 3, 4, 5]. Unilateral PLSVC is an infrequent 
finding with incidence of 18-20% among the individuals 
with this anomaly [1, 6]. However, Biffi et al. report that 
approximately 33% of these subjects may not possess RSVC 
[2]. More frequently, PLSVC is combined with different con-
genital cardiovascular defects such as atrial and ventricular 
septal defects, Fallot’s tetralogy, transposition of the great 
vessels or anomalous pulmonary venous return [3, 4, 7]. Its 
prevalence among these patients reaches 2.8-4.3% [1, 2, 3].
The persistence of the left-sided superior vena cava is an 
effect of disturbances in development of the connection 
between the precardinal veins (anterior cardinal veins) and 
formation of the sinus venosus in early stages of embryogen-
esis. In normal conditions, after the sinus venosus and right 
atrium merging at the end of the eighth week of life, the 
right precardinal vein becomes a privileged one as the short-
est way leading the bloodstream to the heart. Therefore, the 
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left precardinal vein develops anastomosis with the right 
one by the left brachiocephalic vein. As a result, the right 
anterior cardinal vein remains patent forming the superior 
vena cava and the part of the left precardinal vein below 
the connection obliterates becoming a remnant called the 
“ligament of Marshall”. The persistent patency in the lower 
part of the left pericardinal vein results in formation of left 
superior vena cava which typically ends in the right atrium 
reaching it through the coronary sinus [1, 2, 3, 4].
In the majority of cases, PLSVC, when not combined with 
other congenital heart defects, remains hemodynamically 
Figure 2.  Collateral circulation. 1 – azygos vein, 2 – hemiazygos vein, 
3 – internal thoracic veins, 4 – superficial veins. A) Dilated 
thoracic veins visible on chest’s axial scan. B) Dilated and 
meandering azygos and hemiazygos veins presented in 
MIP/oblique reconstruction. C) Wide superficial thoracic and 
internal thoracic veins in volume rendering reconstruction.
Figure 1.  PLSVC infiltrated by the tumor of the left hilum. A) Axial scan – the white arrow indicates PLSVC in the neighborhood of the tumor mass. 
B) MIP reconstruction in oblique projection reveals the vein course.
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asymptomatic [1, 2, 3, 4, 9]. Nevertheless, many authors 
postulate an association between PLSVC and predisposi-
tion to arrhythmias [2, 3, 4, 10]. According to Morgan et al., 
PLSVC occurs in patients with abnormalities of cardiac 
rhythm significantly more often than in general population 
[3]. Clinically, the most important implications of PLSVC are 
difficulties in cardiac catheterization [1, 2, 4, 5, 6, 8, 9, 11]. 
Simultaneously, PLSVC is revealed most frequently during 
this procedure, usually as an incidental finding [4, 11, 12]. 
The diagnosis of the anomaly is also commonly performed 
by transthoracic and transesophageal echocardiography, 
magnetic resonance and computed tomography [13, 14, 15].
Case report
A 62 year – old male, current smoker (20 cigarettes per 
day, for 40 years) have been hospitalized in order to diag-
nose a tumor of the left lung, found on chest x-ray. The 
diagnosis of squamous partially large cell lung carcinoma 
was obtained by bronchoscopy in April 2005. The patient 
underwent CT examination of the chest with an 8-row 
tomograph. The examination was performed in two phase 
protocol after administering the intravenous bolus of 80ml 
of non-ionic contrast medium with an automatic syringe at 
the speed of 4 ml/s. The area of scanning covered the tho-
racic  cavity and the epigastric region. The following para-
meters were used: collimation – 2.5 mm, tube rotation time 
– 0.8 s, 120 kV, 350 mA. Multiplanar and 3D reconstruc-
tions were acquired using dedicated workstations. 
The examination revealed the presence of an extensive 
tumor localized approximately to the upper pole of the left 
hilum. In addition, solitary PLSVC reaching the right atrium 
through the coronary sinus was found. Slight impression 
and modeling of the PLSVC by the tumor were  noticeable 
[Fig. 1]. The patient was qualified to chemotherapy. Six 
cycles of chemotherapy were administered according to the 
Cisplatin and Etoposide scheme. In January 2006, clinical 
and radiological progression of the disease was observed. As 
a second-line treatment, Erlotinib was prescribed. Erlotinib 
is a new registered anticancer molecule, a selective inhibi-
tor of the epidermal growth factor receptor (EGFR) tyrosine 
kinase [16, 17, 18]. From January to October 2006 six fol-
low-up examinations in six- to twelve-week intervals were 
performed using a 64-row tomograph. The scanning area 
included the thoracic, abdominal and pelvic cavities from 
the apices of the lungs to the lower margins of the ischia 
(120 ml of contrast medium, 4 ml/s, tube rotation time 
0.5 s, 120 kV, automatic mAs adjustment). 
CT examination performed in June 2006 presented the 
sings of infiltration of the PLSVC, causing significant nar-
rowing of the vein. Although the vessel still remained pat-
ent, collateral circulation involving azygos/hemiazygos, 
mediastinal and superficial veins of the left part of thorax 
and abdomen developed [Fig. 2]. No clinical symptoms of 
the superior vena caval syndrome (SVCS) were present at 
that time.
Figure 3.  Progressive occlusion of infiltrated PLSVC shown in volume 
rendering reconstructions. A) 24.01.2006 – slight modeling 
of the vein. B) 14.07.2006 – significant narrowing of the vein 
indicated by white arrow. C) 06.10.2006 – complete occlusion 
of the vein.
A B
C
94
© Pol J Radiol, 2007; 72(4): 91-94Case Report
 1. Schummer W, Schummer C, Frober R. Persistent left superior vena 
cava and central venous catheter position: clinical impact illustrated 
by four cases. Surg Radiol Anat, 2003, 25: 315–21.
 2. Biffi M, Boriani G, Frabetti L et al. Left superior vena cava persistence 
in patients undergoing pacemaker or cardioverter-defibrillator 
implantation: a 10-year experience. Chest, 2001, 120: 139–44.
 3. Morgan DR, Hanratty CG, Dixon LJ et al. Anomalies of cardiac 
venous drainage associated with abnormalities of cardiac conduction 
system. Europace, 2002, 4: 281–7.
 4. Pálinkás A, Nagy E, Forster T et al. A case of absent right and persistent 
left superior vena cava. Cardiovasc Ultrasound, 2006, 26; 4: 6.
 5. Leibowitz AB, Halpern NA, Lee MH et al. Left-sided superior vena 
cava: a not-so-unusual vascular anomaly discovered during central 
venous and pulmonary artery catheterization. Crit Care Med, 1992, 
20: 1119–22.
 6. Laurenzi L, Natoli S, Pelagalli L et al. Long-term central venous 
catheterization via persistent left superior vena cava: a case report. 
Support Care Cancer, 2003, 11: 190–2.
 7. Rhodes J, Bacha EA, Geggel RL. Coexistence of three rare congenital 
heart defects in a single patient: a unique case with important 
embryologic implications. Pediatr Cardiol, 2006, 27: 503–7.
 8. Danielpour PJ, Aalberg JK, El-Ramey M et al. Persistent left 
superior vena cava: an incidental finding during central venous 
catheterization – a case report. Vasc Endovascular Surg, 2005, 
39: 109–11.
 9. Sarodia BD, Stoller JK. Persistent left superior vena cava: case report 
and literature review. Respir Care, 2000, 45: 411–6.
 10. Schley P, Thiel A, Shin DI et al. Wolff-Parkinson-White syndrome 
associated with persistent left superior vena cava. M. Horlitz Clin 
Res Cardiol, 2006, 95: 133–5.
 11. Kaemmerer H, Prokop M, Schirg E et al. Unilateral left superior vena 
cava in absent right superior vena cava. Modern imaging diagnosis 
and clinical relevance. Z Kardiol, 1994, 83: 386–91.
 12. Boussuges A, Ambrosi P, Gainnier M et al. Left-sided superior vena 
cava: diagnosis by magnetic resonance imaging. Intensive Care Med, 
1997, 23: 702–3.
 13. Messner GN, Azizzadeh A, Huynh TT et al. Superior vena caval 
bypass using the superficial femoral vein for treatment of superior 
vena cava syndrome. Tex Heart Inst J, 2005, 32: 605–6.
 14. Stavropoulos GP, Hamilton I. Severe superior vena caval syndrome 
after the Mustard repair in a patient with persistent left superior 
vena cava. Eur J Cardiothorac Surg, 1994, 8: 48–50.
 15. Winter FS. Persistent left superior vena cava; survey of world 
literature and report of thirty additional cases. Angiology, 1954, 5: 
90–132.
 16. Dean C, Modjtahedi H, Eccles S et al. Immunotherapy with 
antibodies to the EGF receptor. Int J Cancer Suppl, 1994, 8: 103–7.
 17. Modjtahedi H, Eccles S, Sandle J et al. Differentiation or immune 
destruction: two pathways for therapy of squamous cell carcinomas 
with antibodies to the epidermal growth factor receptor. Cancer Res, 
1994, 54: 1695–701.
 18. Salomon DS, Brandt R, Ciardiello F et al. Epidermal growth factor-
related peptides and their receptors in human malignancies. Crit Rev 
Oncol Hematol, 1995, 19: 183–232.
References:
Another CT examination performed in October 2006 
revealed complete occlusion of the PLSVC with presence of 
strong collateral venous circulation through the routes as 
mentioned above. Clinically, slight SVCS signs, like edema 
of the face and upper extremities with visible dilation of 
the veins, cough and shortness of breath were present. 
The evolution of changes related to infiltration and occlu-
sion of PLSVC is shown on the basis of three selected 
examina tions [Fig. 3].
Discussion
The anatomic variants of systemic venous return such as 
PLSVC are not well-known to all of the radiologists and 
clinicians while in some situations this knowledge may 
be extremely important. Although in our case lung cancer 
of the left hilum was diagnosed before it caused occlusion 
of the PLSVC, the situation when the SVCS is manifested 
and the only radiographic findings on the x-ray picture are 
changes of the left hilum is probable. In such a case, the 
examinations enabling the visualization of the thoracic 
great vessels should be considered with respect to finding 
PLSVC. One of the most appropriate diagnostic techniques 
seems to be multislice spiral computed tomography (MSCT) 
of the chest [11, 12], all the more since the detection of 
PLSVC by plain chest radiographs is considered very dif-
ficult [15]. MSCT allows either the recognition of anomalies 
of the systemic venous return or the diagnosis of patho-
logical changes of the lung hilum, such as tumor or enlarge-
ment of the lymph nodes. In addition, this diagnostic tech-
nique gives an opportunity to detect coexisting changes 
such as metastases or collateral blood flow. Moreover, the 
connections between the systemic veins and the heart, 
as well as their neighboring structures, should be evalu-
ated precisely in regard to surgical procedure as one of the 
methods of treatment of SVCS [13, 14]. The application of 
multiplanar and three-dimensional reconstructions seems 
to be very useful in planning treatment, especially in the 
cases of complex cardiovascular malformations where the 
anatomical topography of the mediastinal structures may 
be atypical [14].
